Abbvie (ABBV) PT Raised to $210 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst Jeffrey La Rosa raised the price target on Abbvie (NYSE: ABBV) to $210.00 (from $206.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
